TELA Bio, Inc.
Clinical trials sponsored by TELA Bio, Inc., explained in plain language.
TELA Bio, Inc.
TELA
NASDAQ
Medical technology company developing biologic mesh for soft tissue repair.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Robotic mesh may patch hernias better Results expected Mar 2027 (estimated)